ArticleChinese medicine2026
Remote electroacupuncture conditioning protects the heart via fine-tuning the dual role of the SDF-1α/CXCR4 axis in myocardial ischemia-reperfusion injury.
Article in Chinese medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundRemote electroacupuncture (EA) conditioning on forearm protects against myocardial ischemia-reperfusion injury (MIRI). However, the cardioprotective mechanisms of RIC have not been fully elucidated. This study aimed to investigate whether EA could balance the pro-survival and pro-inflammatory responses in MIRI rats via SDF-1α/CXCR4 axis.
methodsSD rats were subjected to MIRI and underwent EA treatment before reperfusion therapy. Infarct size, cardiac function, and neutrophil infiltration were evaluated after 24-h of reperfusion. The mRNA and protein levels of SDF-1α in the myocardial border and infarct zones, were measured by RT-qPCR and Western blotting to reveal its spatial distribution. We examined serum SDF-1α levels and its myocardial scavenger receptor CXCR7 expression to elucidate the mechanism underlying its spatial distribution. Then, CXCR4/ERK pathway was evaluated at 15 min and 24 h after EA to examine the time-dependent dual effects of SDF-1α on CXCR4.
resultsOur results showed that EA attenuated infarct size and mortality, improved cardiac function after 24 h of MIRI. We identify that SDF-1α is a key humoral factor mediating EA-induced cardioprotection. In ischemic myocardium, the infarct zone exhibited a higher SDF-1α concentration than the border zone following EA treatment, a difference potentially linked to the elevated expression of CXCR7 in the border zone. In the early phase of reperfusion (15 min), our study showed that EA promoted the expression of the CXCR4 receptor, which in turn triggered ERK activation. This rapid ERK activation via SDF-1α/CXCR4 promoted cardiomyocyte survival and attenuated reperfusion-induced apoptosis. While at 24 h post-reperfusion, saturating signals of SDF-1α by EA downregulated CXCR4 expression, along with phosphorylation of its downstream effectors ERK and NF-κB p65. This coordinated downregulation facilitates inflammatory resolution by promoting neutrophil apoptosis.
conclusionsCardioprotection by EA can be mediated by humoral factors SDF-1α that accumulate in infarct myocardium. SDF-1α triggers pro-survival CXCR4/ERK signaling at 15 min of reperfusion, whereas it promotes neutrophil apoptosis via CXCR4 degradation to facilitate inflammatory resolution by 24 h, thereby fine-tuning the dual role of the SDF-1α/CXCR4 axis in MIRI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.